Mind Medicine Inc

NASDAQ: MNMD    
Share price (5/14/24): $8.49    
Market cap (5/14/24): $610 million

Material Contracts Filter

EX-10.2
from 8-K 28 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 46 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 77 pages Certain Portions of This Exhibit (Indicated by “[***]”) Have Been Omitted Because It Is Both (I) Not Material and (II) Would Be Competitively Harmful if Publicly Disclosed
12/34/56
EX-10.3
from 10-Q 10 pages Directors’ Deferred Share Unit Plan Effective as of April 16, 2021 Amended as of June 8, 2023
12/34/56
EX-10.2
from 10-Q 3 pages Mind Medicine (Mindmed) Inc. Non-Employee Director Compensation Policy Effective as of June 1, 2022 Amended August 11, 2022 Amended June 8, 2023
12/34/56
EX-10
from 10-Q 12 pages Executive Employment Agreement
12/34/56
EX-10
from 10-K 3 pages Mind Medicine (Mindmed) Inc. Stock Option Plan Stock Option Agreement
12/34/56
EX-10
from 10-K 20 pages Mind Medicine (Mindmed) Inc. Performance and Restricted Share Unit Plan 1. Preamble and Definitions 1.1 Title and Conflict. the Plan Described in This Document Shall Be Called the “Performance and Restricted Share Unit Plan”. in the Event of Any Conflict or Inconsistency Between the Plan Described in This Document and the Award Agreement (As Defined Below), the Terms and Conditions of the Award Agreement Shall Prevail. the Plan Shall Be Governed and Interpreted in Accordance With the Laws of the Province of Ontario. 1.2 Purpose of the Plan. the Purposes of the Plan Are: 1.2.1.1 to Promote a Significant Alignment Between Employees and Directors of the Corporation and Its Subsidiaries and the Growth Objectives of the Corporation and Its Subsidiaries; 1.2.1.2 to Associate a Portion of Participating Employees’ and Directors’ Compensation With the Performance of the Corporation and Its Subsidiaries Over the Long Term; and 1.2.1.3 to Attract and Retain Critical Personnel to Drive the Business Success of the Corporation and Its Participating Subsidiaries. 1.3 Definitions. 1.3.1 “Account” Has the Meaning Set Out in Section 5.1. 1.3.2
12/34/56
EX-10
from 10-K 14 pages Mind Medicine (Mindmed) Inc. Stock Option Plan 1. Interpretation in This Plan, the Following Terms Shall Have the Following Meanings: “Administrators” Means the Board Or, if So Designated by the Board to Administer the Plan, the Compensation Committee of the Board or Any Other Designated Members of the Board; “Associate” Has the Meaning Assigned by the Securities Act (Ontario); “Board” Means the Board of Directors of the Corporation; “Cause” Means, in Respect of a Participant: (A) Conviction Of, or the Entry of a Plea of Guilty or No Contest To, Any Criminal or Quasi-Criminal Offence That Causes the Corporation or Its Subsidiaries Public Disgrace or Disrepute, or Adversely Affects the Corporation’s or Its Subsidiaries’ Operations or Financial Performance; (B) Gross Negligence or Willful Misconduct With Respect to the Corporation or Any of Its Subsidiaries in the Course of His or Her Service to the Corporation of Any of Its Subsidiaries;
12/34/56
EX-10
from 10-K 14 pages Mind Medicine (Mindmed) Inc. Stock Option Plan
12/34/56
EX-10.5
from 10-Q 14 pages Executive Employment Agreement
12/34/56
EX-10.4
from 10-Q 16 pages Executive Employment Agreement
12/34/56
EX-10.3
from 10-Q 13 pages Amended and Restated Executive Employment Agreement
12/34/56
EX-10.2
from 10-Q 14 pages Executive Employment Agreement
12/34/56
EX-10.1
from 10-Q 14 pages Executive Employment Agreement
12/34/56
EX-10.4
from 10-Q 7 pages Mind Medicine (MindMed) Inc. One World Trade Center, Suite 8500 New York, Ny 10007 P: (212) 220-Mmed (6633) May 9, 2022 Re: Offer of Employment – Chief Financial Officer
12/34/56
EX-10.3
from 10-Q 15 pages Directors’ Deferred Share Unit Plan Effective as of April 16, 2021
12/34/56
EX-10.2
from 10-Q 4 pages Mind Medicine (MindMed) Inc. Non-Employee Director Compensation Policy Effective as of June 1, 2022 Amended August 11, 2022
12/34/56
EX-10.11
from 10-K 60 pages Supplemental Warrant Agreement
12/34/56
EX-10.10
from 10-K 17 pages Escrow Agreement Among Mind Medicine (MindMed) Inc. and Odyssey Trust Company and Each of the Undersigned Securityholders February 26, 2021
12/34/56